Novartis has a lot cooking with new drug launches, and the company is not letting potential U.S. tariffs on pharmaceuticals ...

As part of Plan Mexico, President Claudia Sheinbaum’s government is moving forward with an expansion project in Manzanillo ...

DC isn’t the only place where regulatory burden-boosting policy proposals are garnering bipartisan support. The same ...

Medpace has historically maintained a conservative balance sheet. At year-end 2024, cash and cash equivalents totaled $669 million. Medpace generated nearly $191 million in cash flow from operating ...

A session dives into the trends surrounding specialty drugs and therapies, along with providing an overview of the drug ...

The FDA has paused a quality control program for milk and dairy products. Food safety experts are concerned, but they say our ...

Imagine materials that build themselves, responding intelligently to their environment to deliver drugs precisely where ...

Guernsey County Sheriff Jeff Paden announced significant prison sentences for three individuals involved in high-level drug ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Novo Nordisk scored a legal win against compounders of its blockbuster GLP-1 drugs. But it may not end the copycats.

Roche posted higher-than-expected first-quarter sales, driven by robust demand for its key drugs, as the company takes active ...